Drug intelligence / Profile preview

2b-B

Development stage
Preclinical
Lead developer
Poznan University of Medical Sciences
Modality
Small Molecules
Administration
Oral, Intranasal
01

Overview

2b-B is a synthetic, symmetric curcuminoid derivative featuring a difluoroboron (BF2) complexed beta-diketone moiety and 2-(morpholin-4-yl)ethoxy substituents. It was developed to overcome the pharmacokinetic limitations of natural curcumin, such as poor water solubility and low bioavailability. 2b-B exhibits approximately 15-33 times higher water solubility than curcumin and demonstrates potent in vitro cytotoxic activity against human bladder cancer cell lines, including 5637 (grade II carcinoma) and SCaBER (squamous cell carcinoma). As a microtubule-targeting agent, it interferes with cellular structural integrity to inhibit tumor cell proliferation. The compound also possesses fluorescent properties, facilitating studies of its intracellular uptake and localization, which typically peaks within two hours of incubation.

Other names
4-(2-{5-[(1E)-2-{2,2-difluoro-6-[(1E)-2-{4-methoxy-3-[2-(morpholin-4-yl)ethoxy]phenyl}ethenyl]-1,3,2-dioxaborinin-4-yl}ethenyl]-2-methoxyphenoxy}ethyl)morpholinemorpholinated curcuminoid BF2 complex
02

Targets

TUBB (Tubulin (alpha and beta subunits))

Beyond the preview

Go deeper on 2b-B.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 2b-B.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call